StockBasis
LIVE · 2026-10-31 05:20 UTC

NEOG Neogen Corp

In Vitro & In Vivo Diagnostic Substances · Nasdaq · SEC EDGAR official

Market Value*
$972.14M
Revenue (FY)
$870.40M 2026-05-31
Net Income (FY)
$-7.90M

second period of the Cenozoic Era.

Financial History annual

Interactive chart · SEC EDGAR annual filings (10-K / 20-F) · enable JavaScript if blank

*Market value = public float disclosed in latest 10-K filing · CIK 711377 · SEC filings · revenue ranking · home